Comparative Pharmacology
Head-to-head clinical analysis: ANCEF IN PLASTIC CONTAINER versus CEFUROXIME.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ANCEF IN PLASTIC CONTAINER versus CEFUROXIME.
ANCEF IN PLASTIC CONTAINER vs CEFUROXIME
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cefazolin, a first-generation cephalosporin, inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), thereby inhibiting peptidoglycan cross-linking and autolytic enzyme inhibition.
Cefuroxime is a second-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), disrupting peptidoglycan cross-linking and leading to cell lysis.
1-2 g IV/IM every 8 hours. Maximum 12 g/day.
250-500 mg orally twice daily; 750 mg-1.5 g IV/IM every 8 hours for moderate infections; 1.5 g IV/IM every 8 hours for severe infections.
None Documented
None Documented
1.5-2 hours in adults with normal renal function; prolonged to 10-30 hours in ESRD (CrCl <10 mL/min); anephric patients up to 40 hours.
Clinical Note
moderateCefuroxime + Probenecid
"The serum concentration of Probenecid can be increased when it is combined with Cefuroxime."
Clinical Note
moderateCefuroxime + Cimetidine
"Cefuroxime can cause a decrease in the absorption of Cimetidine resulting in a reduced serum concentration and potentially a decrease in efficacy."
Clinical Note
moderateCefuroxime + Methantheline
"Cefuroxime can cause a decrease in the absorption of Methantheline resulting in a reduced serum concentration and potentially a decrease in efficacy."
Clinical Note
moderateTerminal elimination half-life is 1.2 hours in adults with normal renal function (increased to 15-22 hours in severe renal impairment [CrCl <10 mL/min], requiring dose adjustment).
Primarily renal (80-96% unchanged within 24 hours via glomerular filtration and tubular secretion); minimal biliary (<1%) and fecal (<1%).
Renal excretion of unchanged drug accounts for 80-90% of elimination via glomerular filtration and tubular secretion; biliary/fecal excretion is minimal (<10%).
Category C
Category A/B
Cephalosporin Antibiotic
Cephalosporin Antibiotic
Cefuroxime + Olanzapine
"Cefuroxime can cause a decrease in the absorption of Olanzapine resulting in a reduced serum concentration and potentially a decrease in efficacy."